Caris Life Sciences (CAI) EBT Margin (2024 - 2026)

Caris Life Sciences (CAI) posted quarterly EBT Margin of 0.3% for Q1 2026, up 8454.0% year-over-year from 0.0% in Q1 2025, and down 101.06% quarter-over-quarter from 27.98% in Q4 2025.

Caris Life Sciences (CAI) EBT Margin (2024 - 2026) Analysis & Trends

Caris Life Sciences' EBT Margin history runs 3 years deep, the most recent figure standing at 0.3% for Q1 2026.

  • In Q1 2026, EBT Margin rose 8454.0% year-over-year to 0.3%; the TTM figure through Mar 2026 stood at 3.73% (up 6416.0% YoY), while the FY2025 annual figure was 8.38%, up 5999.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 0.3%, down from 27.98% in the prior quarter.
  • The five-year high for EBT Margin was 27.98% in Q4 2025, with the low at 84.84% in Q1 2025.
  • The 3-year median for EBT Margin is 34.01% (2024), against an average of 30.84%.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin soared 2658 bps in 2025, then surged 8454 bps in 2026.
  • Caris Life Sciences' EBT Margin stood at 28.44% in 2024, then surged by 198 bps to 27.98% in 2025, then tumbled by 101 bps to 0.3% in 2026.
  • Business Quant data shows CAI's EBT Margin at 0.3% in Q1 2026, 27.98% in Q4 2025, and 11.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Caris Life Sciences 6.16 Bn 5.37 Bn 182.38 Mn -0.23%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.23%
Mar 31, 2026 -0.30%
Dec 31, 2025 27.98%
Sep 30, 2025 11.22%
Jun 30, 2025 -39.58%
Mar 31, 2025 -84.84%
Dec 31, 2024 -28.44%
Sep 30, 2024 -66.65%
Jun 30, 2024 -66.15%